News & Analysis as of

Samsung Bioepis Biosimilars Mylan Pharmaceuticals

Goodwin

Year in Review: Top-Five U.S. Biosimilar Market Developments of 2020

Goodwin on

As we ring in the new year, we look back at the top U.S. biosimilar market developments of 2020. Here are some of our highlights, in no particular order...more

Goodwin

Year in Review: The Top-Five U.S. Market Developments of 2017

Goodwin on

Here are our picks for the top-five most significant U.S. market developments in the world of biosimilars in 2017...more

2 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide